Carl Walkey
Keine laufenden Positionen mehr
Karriereverlauf von Carl Walkey
Ehemalige bekannte Positionen von Carl Walkey
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NEUROGENE INC. | Founder | 01.12.2003 | 01.12.2022 |
| Corporate Officer/Principal | 01.12.2003 | 01.12.2022 | |
| Ansible Marketing, Inc. | Founder | 01.01.2014 | - |
Ausbildung von Carl Walkey
| University of Toronto | Doctorate Degree |
Statistik
International
| Kanada | 3 |
| Vereinigte Staaten | 2 |
Operativ
| Founder | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sektoral
| Consumer Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |
| Ansible Marketing, Inc. |
- Börse
- Insiders
- Carl Walkey
- Erfahrung
